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Though it has been a focus of the country’s public health surveillance systems since the 1950s, schistosomiasis
represents an ongoing public health challenge in China. Parallel, schistosomiasis-specific surveillance systems have
been essential to China’s decades-long campaign to reduce the prevalence of the disease, and have contributed to
the successful elimination in five of China’s twelve historically endemic provinces, and to the achievement of
morbidity and transmission control in the other seven. More recently, an ambitious goal of achieving nation-wide
transmission interruption by 2020 has been proposed. This paper details how schistosomiasis surveillance systems
have been structured and restructured within China’s evolving public health system, and how parallel surveillance
activities have provided an information system that has been integral to the characterization of, response to, and
control of the disease. With the ongoing threat of re-emergence of schistosomiasis in areas previously considered
to have achieved transmission control, a critical examination of China’s current surveillance capabilities is needed
to direct future investments in health information systems and to enable improved coordination between systems in
support of ongoing control. Lessons drawn from China’s experience are applied to the current global movement
to reduce the burden of helminthiases, where surveillance capacity based on improved diagnostics is urgently needed.
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Schistosomiasis poses a major public health threat in many
tropical and sub-tropical countries—the disease is endemic
to 78 countries worldwide and, in 2011, at least 243 million
people were infected and needed treatment [1]. In China,
despite substantial progress achieved reducing the burden
of schistosomiasis over the past two decades, the disease
remains an ongoing public health challenge [2,3]. Based on
the most recent data, nearly 250,000 people are estimated
to be infected in 171 counties in China [4]. Since the
1950s, endemic areas have been identified in 454 counties
in 12 provinces [3,4]. As of 2012, transmission had been
eliminated in 5 of the 12 endemic provinces, and morbidity
and transmission control had been attained in the other 7
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unless otherwise stated.[5,6]). The country has set an ambitious goal of achieving
nation-wide transmission interruption by 2020, however
several obstacles lie in the way, including re-emergence in
previously controlled areas [7], as well as challenges achiev-
ing lasting interruption of transmission in remaining
endemic foci [3,4].
China’s multiple, evolving surveillance systems for
schistosomiasis have been integral to the country’s
decades-long campaign to reduce the prevalence of the
disease. Chinese surveillance for schistosomiasis began in
the middle of the 20th century after the founding of
the People’s Republic, with identification of endemic
areas through both hospital-based reporting and limited
epidemiological surveys. Currently, there are four parallel
surveillance systems specific to schistosomiasis (Table 2)—
routine surveillance, national surveys, sentinel surveillance
and the national infectious disease reporting system
(NIDRS). These systems serve distinct, but complementary
purposes. The routine surveillance system (termed ‘routinetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
able 1 Criteria for assigning county-level schistosomiasis
ransmission status
ransmission status Criteria
fection control Human infection prevalence <5%
Bovine infection prevalence <5%
<10 acute cases over 2 week period
in a village
ransmission control Human infection prevalence <1%
Bovine infection prevalence <1%
No acute cases
No infected snails (O. hupensis) for
two consecutive years
ransmission interruption No human cases for five consecutive
years
No bovine cases for five consecutive
years
No snails (O. hupensis) for two consecutive
years
limination No new infection in humans or bovines
for five years after reaching transmission
interruption
ote: All criteria are evaluated at the administrative village-level.








Nsurveys’ in some literature), was initiated in the 1950s.
The other three schistosomiasis surveillance systems cre-
ated in the late 1980s were strengthened considerably in
1992 when the Chinese government received a long-term
World Bank loan aimed at improving schistosomiasis
morbidity control. The loan resulted in significant in-
vestment in schistosomiasis research [8] and disease con-
trol efforts, as well as financial support for the national
and routine surveillance systems [8,9].
Schistosomiasis, like many neglected tropical diseases
and other human helminthiases in particular, presents sev-
eral surveillance challenges. First, the disease is typically
concentrated in low-income, rural areas where health in-
frastructure is limited. Second, the clinical presentation of
the disease is rarely acute, and like many chronic diseases,
long-term infections can evade clinical detection and
eventually lead to severe health sequelae later in life. Thus
reliance on passive hospital or clinic-based reporting
can grossly underestimate the number of infections.
China’s long history conducting schistosomiasis surveil-
lance through multiple systems presents a unique op-
portunity to examine how their complementary structures,
designs and sampling approaches—and their evolution over
time—have provided essential epidemiological information
to support the control of a neglected tropical disease.
The goal of this paper is to detail how China's schisto-
somiasis surveillance systems have been structured and
restructured as part of China’s evolving public health
system, yielding a combined information system that has
been integral to the country's progress in reducing the bur-
den of the disease. We discuss the diagnostic approachesunderlying these systems, as well as additional tools ne-
cessary for cost-effective schistosomiasis surveillance in
endemic settings that are approaching transmission control
and elimination but face the threat of re-emergence. Finally,
we discuss ways in which China’s experience with schisto-
somiasis surveillance can offer insights to other countries
as they develop and strengthen their own infectious disease
surveillance systems.
Diagnostic methods for detecting schistosomiasis
infections in humans and animals
China’s schistosomiasis surveillance programs target three
key hosts: humans, bovines and snails. Assays to detect
schistosomiasis infections in human hosts are used to pro-
vide a direct measure of disease burden in the population,
whereas surveys of bovines and snails (spatial distribution
and infections) provide a means to evaluate the transmis-
sion potential of a given setting, and the particular role
played by non-human reservoirs.
Detection of human infections
Detection of schistosomiasis infections in humans in
China is typically accomplished by immunologic or copro-
logic assays. Immunologic assays commonly used in China
include Schistosoma japonicum-specific immunoglobulin G
standardized enzyme-linked immunosorbent assay (ELISA)
and the indirect hemagglutination assay (IHA). Diagnostic
immunological test kits have historically been subsidized
by the national government, which has contributed to
their widespread use. From a practical standpoint, im-
munologic methods are desirable as they require only a
blood sample from a finger or ear-stick. Immunoassays
generally have high sensitivity, but low specificity, due
in part to the inability of the assay to distinguish between
past and current infections [10]. The immunological tests
are generally used as a first-step screening method in large
population surveys: those who test positive by immuno-
assay are then tested with a coprologic exam.
China relies on the Kato-Katz technique as the primary
coprologic schistosomiasis diagnostic, following guidance
of the World Health Organization [11]. The method in-
volves the microscopic examination of a stool sample
smeared across three slides using a light microscope.
Slides are examined by trained laboratory technicians who
count Schistosoma eggs in standardized 41.7 mg smears
and calculate eggs per gram (EPG) of the original sample,
providing a widely accepted proxy measure of infection
intensity [12]. The assay lacks sensitivity in low infection-
intensity regions [13,14].
Another common coprologic assay is the miracidium
hatch test, which detects the presence of viable schistosome
eggs in stool by inducing miracidia to hatch in an aque-
ous solution. Typically performed in county-level anti-
schistosomiasis stations, 30 g stool samples are strained
Table 2 Summary of key characteristics of current schistosomiasis surveillance systems in China
NIDRS Sentinel Routine National
Active/passive Passive Active Active Active
Year initiated 1950s (1989 for schistosomiasis) 1990 1950s 1989
Reporting unit Individuals in hospitals Sentinel village Village Village
Coverage All hospitals Nine sentinel villages All villages in endemic counties 1% of villages in endemic
provinces
Time frame Real-time, within 24 hours of
patient diagnosis
Yearly All villages sampled over ~3 years, reporting
occurs at completion of each village’s survey
Periodic every 6-9 years:
1989, 1995, 2004
Purpose Aid understanding of disease patterns;
provide evidence for policy-making
Longitudinally and objectively monitor
how the schistosome-endemic situation
changes over time
Evaluate control measures Clarify the endemic status of
schistosomiasis as established
by the previous national survey
Information collected Individual cases (demographics,
patient residence, diagnosis, treatment
and hospital)
Snail habitat, human infection prevalence
and intensity, bovine infection prevalence
Snail habitat, human infection prevalence Human infection prevalence
and intensity, bovine infection
prevalence, snail habitat
Diagnostics Clinical and laboratory IHA screen then Kato-Katz and miracidium
hatch
IHA screen then Kato-Katz ELISA screen then Kato-Katz
Major changes 2004: Replaced paper-based monthly
or yearly reporting with internet-based
real-time reporting system
2011: Added Miracidium Hatch Test
to diagnostic procedure
2011: Replaced yearly reporting with
internet-based parasitic disease reporting







Strengths Inexpensive, Algorithms can be created
to automatically detect outbreaks of
emerging or reemerging disease
Provides longitudinal measures of disease
prevalence and intensity
Provides greatest coverage since it





Limitations Underreporting of chronic cases; potential
underreporting of acute cases due to
political pressure; potential information bias
associated with variable clinical and diagnostic
capacities of reporting sites; non-response
bias associated with reporter fatigue
Sampling occurs at limited sites (20 in
1989, 80 in 2005); longitudinal follow-up
over decades can yield non-response bias
resulting from participation and reporter
fatigue; potential selection bias associated
with the choice of villages to sample
longitudinally
Variable clinical and diagnostic capabilities
can lead to information bias; potential
selection bias associated with choice of
survey sites, since those in charge of
surveillance are also in charge of control
efforts; potential reporting bias as funding
can be tied to disease control success;
potential non-response bias resulting from
participation fatigue and temporary
rural-to-urban migration
Occurs rarely and survey
methods change, making
it difficult to assess temporal
patterns; only includes 1% of
endemic villages in each
province
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some eggs and remove small particles. The enmeshed
material is then suspended in an aqueous solution, and
placed in a lit, temperature-controlled environment where
the sample is examined at two, five and eight hours for the
presence of miracidia using low magnification [14].
Detection of bovine infections
Detection of S. japonicum in the bovine population serves
as a complement to human surveillance, as bovines are a
key non-human reservoir of S. japonicum in China. Thus
detection of infections in bovines offers a means of moni-
toring the role of non-human hosts in introducing or
sustaining transmission, particularly in agricultural set-
tings where bovines are abundant [14]. To test bovines
for infection, a variant of the miracidium hatch test is
used with modified observation times. Because the high
water content of bovine stool can promote rapid hatching,
the suspended sample is typically examined at shorter
time intervals (one, two, and four hours) after preparation
relative to the human exam [15].
Quantification of intermediate host densities and infections
Assessments of the density and infection status of the
intermediate snail host Oncomelania hupensis have long
played an important role in China’s surveillance for
schistosomiasis. Snail density surveys consist of collecting
and counting snails from historical or newly identified
snail habitat. Specimens are drawn from a consistent
kuang-sized (0.11 m2) sampling frame at random or
equal interval points along streams, irrigation canals,
fields, and lakes in endemic and some formerly endemic
areas [7]. The infection status of sampled specimens is de-
termined by microscopic examination for the presence of
cercariae. This method is limited in that it is only capable
of detecting patent infections, and even in regions where
human infection prevalence is high, the prevalence of S.
japonicum infections in snails is very low (<<1%; [16]),
and thus screening of a large number of snail hosts is
needed. In areas where human infection prevalence is low,
infected snails are rare and a poor indicator of the pres-
ence of human infections [14].
Future diagnostic needs
As schistosomiasis infection prevalence declines in China,
more sensitive diagnostic methods are needed [14]. Recent
diagnostic innovations include methods that detect S.
japonicum DNA in human and bovine stool or serum,
as well as in snails [17-19], but these assays have not yet
been widely adopted. Such approaches offer potentially
greater sensitivity than existing methods, particularly in
areas where infection intensities are low, which is a key
technological need for schistosomiasis elimination [20]. Is-
sues of cost, standardization, laboratory infrastructure andtechnical training remain to be addressed for this new
class of molecular diagnostic techniques.
History of institutional support for schistosomiasis
surveillance in China
In 1956, a massive nationwide schistosomiasis control cam-
paign was launched, which bore the slogan “Schistosomiasis
has to be eliminated” and was subsequently memorialized
by Chairman Mao Zedong’s poem “Farewell to the God of
Plague” in which he mourned the advance of the disease
and championed its subsequent retreat [21,22]. Medical
school graduates were required to spend time in rural
areas, both to provide care directly as village doctors,
as well as to train local residents to serve as paramedics,
or so-called barefoot doctors [23,24]. At the same time,
China established administrative and professional health
organizations at varying levels of government to carry out
both surveillance and control tasks aimed at eliminating
specific diseases. These included an Office of Endemic
Disease (OED) in each province, which designed and
managed surveillance and control programs, as well as
units targeting specific infections. For schistosomiasis,
county-level anti-schistosomiasis stations were estab-
lished under the supervision of OEDs and were respon-
sible for carrying out surveys on humans and the snail
intermediate host, control activities and health education.
These stations established the necessary infrastructure and
recording procedures for documenting infection and treat-
ment statuses, disease progression of patients, and distri-
bution and abundance of the intermediate host of the
pathogen, and hence played a central role in the first stan-
dardized schistosomiasis surveillance activities [7].
In the late 1970s, reforms to China’s health systems led to
the dismantling of the cooperative health system in place of
a market-based system, and by 1985, barefoot doctors
either became village doctors who worked on a fee-for-
service basis, or they shifted to other professions [25].
This substantial change in government policy led to a
dramatic decline in primary health care coverage in
rural areas. The restructuring of the public health sys-
tem also involved the establishment of Epidemic Preven-
tion Stations (EPS) at provincial, prefecture and county
administrative levels, with a vertical structure for disease
reporting and for the provision of technical guidance [26].
Provincial, prefecture, and county EPS were financed by
the health bureau at the same administrative level, result-
ing in little administrative control of higher-level EPS over
lower-level institutions (although technical guidance did
flow from higher- to lower-level units). Prefecture and
county EPS primarily reported to their local health bureau
instead of provincial EPS or the Ministry of Health. This
structure would change dramatically with the most recent
major overhaul of China’s heath systems at the turn of the
21st century [26,27].
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Prevention and Control (China CDC) was established
from the former Chinese Academy of Preventive Medicine
[27]. With the founding of China CDC, nearly all institu-
tions responsible for disease control were integrated into a
single system that linked national, provincial, prefecture
and county levels. All levels of EPS were converted to
CDCs and linked with other CDCs in a vertical structure
that persists to this day (Figure 1; [27]).
China’s evolving schistosomiasis surveillance systems
Surveillance was spotty and inconsistent in the years fol-
lowing the founding of People’s Republic of China, and
not until 1989 did robust schistosomiasis surveillance pro-
grams emerge [28]. A massive, national survey in 1989
confirmed endemic counties and assessed schistosomiasis
prevalence status in 12 provinces based on human infec-
tions and an assessment of intermediate host habitat [29].
Starting in 1992, additional schistosomiasis surveillance
systems came online, including annual, locally adminis-
tered surveys in endemic villages, as well as intensive
national surveys to estimate the prevalence of schisto-
somiasis across provinces and in several high priority
areas [30]. In 2003, the SARS epidemic exposed key weak-
nesses in China’s ability to detect and manage infectious
disease epidemics [31]. In response, the Chinese govern-
ment invested heavily in an enhanced National Infectious
Disease Reporting system (NIDRS), which launched in
2004. The overhauled NIDRS was fully internet-based,
and the number of reportable diseases was increased to
reflect the country’s need for key surveillance data to
support infectious disease prevention and control pro-
grams. At the same time, China’s entire public health
system was being streamlined as described above, lead-
ing to the formation of China CDC [32].
Coincident with this massive transformation of China’s
public health institutions, a large World Bank loan that
supported schistosomiasis control programs was ending,Figure 1 Structure of China’s Public Health System after 2002 [44].and its completion in 2001 resulted in a significant loss
of funding for schistosomiasis surveillance. Surveillance
and control efforts decreased, contributing to the re-
emergence of schistosomiasis in several locations where
it had previously been controlled [7,33]. In response, the
Chinese Ministry of Health included schistosomiasis on a
list of four infectious diseases targeted with high priority
for surveillance and control, along with tuberculosis, HIV/
AIDS and Hepatitis B. This was a major policy change,
establishing schistosomiasis control as a national prior-
ity and elevating the position of the disease on the list of
nationally notifiable diseases (i.e., from class C to class B;
Table 3). Improvements in schistosomiasis surveillance
followed, as increased commitment and funding flowed
from the central government.
In the following sections, we describe the purpose,
sampling approach, and diagnostics used in each of the
four schistosomiasis surveillance systems—routine surveys,
national surveys, sentinel surveys and NIDRS—and we
describe how each surveillance system was impacted by
changes in China’s health systems following the SARS
epidemic in 2004.
Routine surveys
Routine schistosomiasis surveys involve periodic infection
screening in every endemic village in the seven endemic
provinces. Staff at county-level anti-schistosomiasis sta-
tions have historically conducted these screenings in col-
laboration with local village governments and hospitals
[7]. Routine surveys generate data used by the Ministry of
Health to evaluate control measures, and provide informa-
tion used by provincial-level schistosomiasis control steer-
ing committees to determine which counties have satisfied
the official criteria for transmission control (Table 1). The
primary outcomes and other characteristics of routine
surveys are summarized in Table 2.
Changes since 2004
With the substantial increase in central government sup-
port for schistosomiasis control since 2004 [34], local
anti-schistosomiasis stations began receiving funding dir-
ectly from the central government to carry out and improve
routine surveys, and to implement interventions based on
survey findings. Because anti-schistosomiasis stations are
responsible for both surveillance and control, and the fund-
ing they receive from the national government is in part
correlated to control success, reporting bias may be present
in routine surveillance data. The national and provincial
health bureaus set annual goals (e.g., prevalence reduc-
tion targets) for anti-schistosomiasis stations, which were
folded into annual control performance reviews for the sta-
tions. To improve reliability of these surveys, a real-time,
internet-based reporting system was established in 2011 to
file, store and manage routine survey data [35], and quality
Table 3 Infectious diseases covered by mandatory NIDRS reporting [31]
Rank # of diseases Reporting time Diseases
Class A 2 2 hours Plague, Cholera
Class B 26 24 hours§ SARS§, HIV/AIDS, Viral hepatitis (A, B, C, E, other), Poliomyelitis§, Human avian influenza§,
Measles, Epidemic hemorrhagic fever, Rabies, Epidemic Japanese encephalitis B,
Dengue fever, Anthrax§, Tuberculosis, Dysentery (viral or amebic), Epidemic cerebrospinal
meningitis, Typhoid and Paratyphoid, Pertussis, Diphtheria, Tetanus neonatorum, Scarlet
fever, Brucellosis, Gonorrhea, Syphilis, Leptospirosis, Schistosomiasis, Malaria, H1N1 swine flu
Class C 11 24 hours Influenza, Mumps, Rubella, Acute hemorrhagic conjunctivitis, Leprosy, Typhus, Leishmaniasis,
Echinococcosis, Filariasis, Infectious Diarrhea other than cholera, dysentery or typhoid and
paratyphoid, Foot-and-mouth disease
§Cases of SARS, poliomyelitis, pulmonary anthrax and human infection with highly pathogenic avian influenza must be reported within 2 hours.
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records to detect and reduce reporting biases.
Sampling methodology
Routine surveys in a given endemic county are typically
conducted over the course of two, three or more years
depending on the level of endemicity in—and the control
status of—the county. For counties that have achieved
transmission control (Table 1), all villages are surveyed
over a three-year period (i.e., one-third of villages in the
county are surveyed each year). In counties that have
achieved transmission interruption, all villages are sur-
veyed over four- or five-year periods, and in counties that
have yet to achieve transmission control, all villages are
surveyed over two years. Villages are randomly selected
and grouped into two (for counties not yet achieving
transmission control), three (for counties achieving trans-
mission control), or four or five (for counties achieving
transmission interruption) subgroups. Each year, one sub-
group of villages is surveyed, and this is repeated annually
until all subgroups are surveyed. At that point, villages are
randomly grouped into new subgroups, and the multi-
year survey process is repeated. In villages that are part
of the sentinel schistosomiasis surveillance system (see
below), routine surveys are not conducted and the ne-
cessary information is shared from the sentinel system.
In a given village, routine surveillance involves inter-
mediate host surveys in the spring followed by surveys
of the human population in the fall, at the end of the
transmission season. The target human sample is >90%
of residents between the ages of 6 and 65 years old [9].
Sampling of cattle and other alternative mammalian hosts
are also included in routine survey efforts, but these are
the responsibility of the local animal husbandry depart-
ment and the degree of coordination between the veter-
inary and public health efforts is highly variable [7]. All
residents are requested to present themselves at a des-
ignated location for screening on the day of the survey.
Villager participation in these surveys has been incon-
sistent. Residents may not feel ill and therefore may see
no need to be tested for schistosomiasis. In endemic
areas, surveys have been completed every year or everyother year for >50 years, leading to participation fatigue. To
overcome this challenge, health workers have conducted
health education campaigns that emphasize the impacts of
undetected, chronic infections, and the importance of
routine schistosomiasis examinations. When residents
are missed by a routine survey screening, public health
workers will seek them out in their homes and request
their participation.
Sampling and screening protocols for routine surveys
are standardized by the Ministry of Health to improve
consistency between counties and provinces, though var-
iations have been noted. In Sichuan Province, for example,
different diagnostics have been used between counties,
some carrying out serologic exams only, some serologic
followed by stool exams and some stool exams only. Thus,
there are limitations when directly comparing routine
survey data between counties.
Relationship to routine surveillance systems for other
parasites and diseases
In China, routine surveys are unique to schistosomiasis,
providing spatial and temporal data on infection patterns
that are generally unavailable for other parasitic diseases.
The surveys are very resource-intensive, and thus they have
not been adopted, for instance, for soil-transmitted hel-
minths (STHs). A sentinel STH system exists and resem-
bles routine schistosomiasis surveys with less exhaustive
sampling. The standardized training of county-level staff
that carry out routine survey screenings—and the infra-
structure developed to support them—have provided on-
going quantitative data on the distribution of cases at fine
spatial scales [36]. These data are unique to schistosomiasis,
and have provided essential information to schistosomiasis
reduction programs throughout China.
National surveys
In 1989, China carried out the first national schistosomiasis
survey with the purpose of estimating the prevalence of the
disease in each endemic province. The resulting informa-
tion served as an important baseline dataset for the World
Bank loan for schistosomiasis control (see Introduction),
and the 1989 data were subsequently compared with
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the loan-financed programs [37]. National surveys are
large, periodic cross-sectional studies that generate
estimates of prevalence among humans and domestic
animals across endemic settings. They are carried out
every 6–9 years in China, and their primary outcomes
and other characteristics are summarized in Table 2.Changes since 2004
The most recent national schistosomiasis survey in 2004
included considerable technical improvements over pre-
vious surveys, such as an additional sampling stratum
targeting low intensity infection areas; use of ultrasonog-
raphy to screen a small number of subjects tested for
schistosome-induced fibrosis; use of a subset of surveyed
villages to assess the sensitivity of the Kato-Katz test as
performed by Chinese technicians [28]; and sampling to
estimate snail density and snail infection prevalence in
one county within each province [37]. Importantly, the
2004 national survey included all formerly endemic areas
that had achieved infection control and transmission con-
trol (see Table 1), whereas previous surveys focused on
formerly endemic areas that had achieved infection con-
trol only. These and other changes to the national survey
sampling design in 2004 provided important information
as China oriented its control programs towards national
elimination, but also generated survey results that were
not directly comparable to the 1989 or 1995 surveys [28].Sampling methodology
National surveys are mandated by the Chinese Ministry
of Health, but are designed, managed and overseen by
the OEDs in the seven endemic provinces [28]. The sam-
pling unit is endemic administrative villages, as defined by
a combination of data from the preceding national survey
and preceding years of routine survey data. The sampling
design is based on a stratified cluster random sampling
across three strata: (1) province, (2) environment/ecotype,
and (3) estimated local prevalence based on the most re-
cent routine survey data (Figure 2). All residents 6 to
65 years old are eligible to participate in national surveys,
and the ELISA method is used for initial screening,
followed by Kato-Katz exams to confirm and quantify
infection for all ELISA positives [28].
Because national surveys use standardized sampling
methodologies, the results are comparable between prov-
inces. What is more, the Ministry of Health uses the
national surveys’ representative population sampling strat-
egy to estimate prevalence across each endemic province
while decreasing the required size of the sample. However,
the sampled population, chosen in part based on historical
prevalence, may not be representative [28].Relationship to national surveys for other parasitic
diseases
The Chinese government has historically carried out
national surveys for other human parasitic diseases [38].
Between 1988 and 1992, and again between 2001 and 2004,
national surveys tested for 56 different parasites, including
protozoa and helminths [28,39], using a random sampling
scheme and a set of diagnostics similar to the national
schistosomiasis surveys [40]. However, sampling for these
national surveys was not informed by routine surveillance
data. Thus, in the absence of recent prevalence data, socio-
economic factors—including variables such as sanitation
access, income and literacy—were used to stratify the
population for sampling.
Ad hoc provincial surveys following national survey
protocols
As an example of how new surveillance capacity can fol-
low on existing efforts, some provinces carry out provincial
schistosomiasis sampling surveys borrowing sampling
methodology from the 1989 and 1995 national surveys,
but with the purpose of including a larger population
within the province to boost sensitivity. Provincial OEDs
design provincial survey sampling protocols, including hu-
man, bovine and intermediate host surveys, and surveys
are carried out by anti-schistosomiasis stations in each
county with the support of the EPS. Endemic villages from
each county are sampled randomly within three categories
based on infection prevalence and infection intensity de-
termined from prior routine surveys, as follows. One third
of endemic villages are randomly selected from each of
three categories of infection prevalence based on results
from routine surveys: less than five percent prevalence; be-
tween 5 and 15 percent; and >15 percent. In settings with
low variability in infection prevalence between villages,
sampling is based on infection intensities, with one third
of villages sampled each from light, medium and heavy
infection categories, again based on the results of recent
routine surveys. In Sichuan’s provincial survey in 2001, for
instance, 1,188 villages were sampled, involving >1,810,000
people ranging from age 5 to 65. The survey took six
months to complete, from April to October, and all cattle
were screened in each sampled village. For comparison,
for the national surveys in Sichuan, >52,000 people from
39 villages, and >51,000 people from 40 villages, were sur-
veyed respectively in 1989 and 1995. The more intensive
sampling regimen of the provincial survey provided more
detailed spatial coverage than the national survey.
National sentinel surveillance
The sentinel schistosomiasis surveillance system was ini-
tiated in 1989 with 20 sites in the seven endemic prov-
inces, selected to represent different eco-epidemiological
zones of transmission [9]. The purpose of the sentinel
Figure 2 Sampling design for the 1989 and 1995 national schistosomiasis surveys [36]. A stratified cluster random sampling design with
three strata was used. The first sampling stratum includes the seven schistosomiasis-endemic provinces (Jiangsu, Anhui, Jiangxi, Hubei, Hunan, Sichuan,
and Yunnan) and one controlled province (Zhejiang). For endemic provinces, environmental and ecosystem characteristics were used to define the first
sub-stratum (eco-type), and the level of prevalence defined the second sub-stratum (prevalence). A target survey population was drawn from each of
the second sub-strata, with the characteristics defined in the figure. For areas that have achieved control (Zhejiang province in the 1989 and
1995 national surveys), the target survey population was drawn from two administrative villages from each historically endemic county.
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intensity. Sentinel surveys consist of human and bovine in-
fection screening—along with snail surveys—with the pur-
pose of capturing temporal changes in prevalence and
intensity of infection [9]. For example, in Sichuan Province
there are four counties enrolled in sentinel surveillance—
Xichang, Dangling, Guanghan and Pujiang—where snail
sampling takes place two times a year, in late spring and in
fall, and human and animal surveys are conducted in the
fall [9]. Within each county, one village is selected each
year where at least 90% of village residents over the age of
six are sampled.
Changes since 2004
The sentinel system expanded in 2005 to include 80 sites
across China, reflecting the Chinese government’s increased
commitment and funding to schistosomiasis surveillance
and control. In Sichuan Province, the number of sentinel
sites increased from four to nine, and of these, six are in
hilly regions, one is from a plateau region, and two are from
mountainous areas. Hilly areas are represented with the
most sentinel sites because infections in Sichuan are most
common in these regions. The nine Sichuan sites have
remained constant since 2005, and there is a commitment
to continue longitudinal tracking of schistosomiasis infec-
tions in these sites regardless of their transmission trajec-
tories in order to take maximum advantage of a consistent
longitudinal dataset.Diagnostic protocols for the sentinel system have chan-
ged to accommodate the changing transmission profiles
of sentinel sites, particularly challenges in detecting low-
intensity infections. As of 2011, for instance, sentinel sites
in Sichuan Province test all those classified as positive
using a serologic assay with both Kato-Katz and a miracid-
ium hatch test. These multiple rounds of diagnoses, and a
history of intensive surveillance generally in these historic-
ally endemic regions, have led to community-wide surveil-
lance fatigue in some sentinel sites. Costs of implementing
the ongoing sentinel surveillance are likely to increase as it
becomes more challenging to achieve high levels of
community participation, necessitating more intensive
follow-up with residents and more sensitive diagnostic
methods.
Sampling methodology
The number of sentinel sites sustained by the system is
based on the level of funding provided by the central gov-
ernment, and provinces with higher prevalence and infec-
tion intensity are allotted more resources (and thus sites).
To select sites, national and provincial level OEDs con-
sider two factors: variation in infection intensity (sites are
selected from communities with heavy, medium and light
infections based on infection intensity measurements from
prior routine surveillance); and eco-epidemiological zone
(e.g., plateau, lake, hilly or mountainous regions). Sentinel
system screening has been conducted by Kato-Katz since
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found positive by IHA confirmed with the Kato-Katz exam.
If acute or advanced cases are found, epidemiological in-
vestigations are conducted to collect more detailed infor-
mation about each case.
The overall design of the sentinel system was developed
and approved by a national steering committee, yielding a
system that is consistent among all surveillance sites, and
making the data comparable between sites in all seven en-
demic provinces. It is sometimes necessary to move sites
when implementing an intensive longitudinal surveillance
system. For instance, after >10 years at one site in Sichuan,
the population exhibited fatigue from yearly surveys and a
new site was substituted to increase community participa-
tion. In one instance, as infection intensity and prevalence
decreased dramatically across Sichuan Province, a very
low prevalence sentinel site was replaced with a high
prevalence site. Substituting sites interrupts the sentinel
surveillance time-series, and data at new sites provide
few insights into temporal trends until the series is allowed
to accumulate over a number of years.National infectious disease reporting system
The National infectious disease reporting system (NIDRS)
was established in the 1950s [31], but it was not until
1989, with the passing of China’s Law on Preventing and
Treating Infectious Diseases, that the reporting of selected
infectious diseases was mandated by law [32]. The NIDRS
has historically involved a vertical reporting structure
where hospitals reported the aggregated number of cases
monthly by post to the county health department, who
in turn report aggregate cases to the prefecture, then to
the province, and finally to the central government. The
information is used by Chinese public health officials to
understand national patterns of infectious disease trans-
mission, and to develop appropriate prevention and
control programs [41].Changes since 2004
Following the SARS outbreak, China’s Law on Prevent-
ing and Treating Infectious Diseases was revised, and
the NIDRS was transformed into an internet-based, real-
time system [31]. The new system involves the routing
of individual cases (rather than strictly aggregated data)
up the hierarchy of public health institutions. The system
provides for timely reporting of schistosomiasis cases to
public health officials, allowing for rapid identification of,
and response to, suspected re-emergence of the disease.
The reporting of individual cases also enhances the spatial
and temporal resolution of disease reporting, allowing for
assessment of, for example, seasonal trends and persistent
hot-spots of transmission [31].Sampling methodology
Cases of schistosomiasis diagnosed in clinics or hospitals
are reported directly to the NIDRS. Reporting includes
both acute and chronic cases, however acute schistosom-
iasis contributes a disproportionate number of reported
schistosomiasis cases. Acute schistosomiasis is a severe al-
lergic reaction to the migrating schistosomule in the blood
stream following infection and typically occurs only in
naïve populations such as children or military personnel
deployed to a new region. The rapid onset of severe symp-
toms typical of acute schistosomiasis is more likely to
prompt health-seeking behavior, therefore resulting in
more frequent capture by NIDRS [42]. Because the symp-
toms of chronic S. japonicum infection are non-specific
and often sub-clinical, chronic infections are poorly cap-
tured by clinic-based surveillance. Thus NIDRS schisto-
somiasis surveillance is considered key for identifying
areas of disease emergence (or re-emergence), but not
for assessing infection prevalence. What is more, diag-
nosis of a reported case is coded in the NIDRS as using
either a clinical or a laboratory diagnostic, without fur-
ther differentiation such as between stool and serologic
exams [43]. The primary outcomes and other character-
istics of the NIDRS system are listed in Table 2.
Schistosomiasis diagnostic and clinical capabilities, and
therefore reporting capacity, differ considerably across
China, and the transition to the internet-based NIDRS
revealed several limitations of surveillance capacity in
China [31]. The availability of computing resources and
internet coverage required to connect directly to NIDRS
varied within and between provinces, limiting the gener-
ation and transmission of electronic case reports [44].
Hospitals that lack sufficient information technology re-
sources were required to send paper forms to the county
CDC for entry into the online system, introducing a report-
ing delay. A national initiative was launched to equip such
hospitals with computer workstations and network cover-
age, resulting in the delivery of >4,000 computers to hospi-
tals and clinics in Sichuan Province in 2005, for example
[45]. Other challenges were revealed relating to disparities
in clinical resources. For instance, a disproportionate num-
ber of the cases of schistosomiasis present in NIDRS have
been reported by county-level hospitals, in part because
diagnostic capabilities are poorer at township-level hos-
pitals, and diagnostic capabilities for parasitic diseases
are sometimes entirely absent at private clinics and village
healthcare centers [46].
Relationship to reporting systems for other diseases
At present, the NIDRS covers 39 infectious diseases in three
classes based on their public health importance (Table 3;
[47]). The Class A list includes two diseases, cholera and
plague, that are required to be reported within two hours of
diagnosis. Pulmonary anthrax, SARS, poliomyelitis, and
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are in Class B, and are also required to be reported within
two hours. Other Class B and Class C diseases must be
reported within 24 hours of diagnosis. Class C diseases
include newly identified diseases or diseases with emer-
ging public health importance, including foot and mouth
disease. Schistosomiasis was listed as a Class B nationally
reportable infectious disease in 2004 [47], in part to
rapidly capture reports of acute cases that may signal an
outbreak of infection [43].
Future directions in surveillance
Ideally, surveillance systems provide data that support
evidence-based policy decisions and contribute to effect-
ive and efficient disease control [48,49]. Additionally, ef-
fective surveillance systems must respond to advances in
technology and changes in programmatic goals. While mul-
tiple, complementary systems can provide rich spatial and
temporal information on the distribution of cases, resource
constraints necessitate surveillance systems that minimize
redundancies, particularly in low- and middle-income
countries.
Key factors in the evolution of China’s schistosomiasis
surveillance over the past six decades include the World
Bank loan (and the rise in cases following its termination
in 2001); changes in the epidemiology of schistosomiasis;
changes in available technologies for diagnosis and treat-
ment [50]; and major public health events such as the
2003 SARS epidemic. The SARS epidemic in particular
revealed weaknesses in China’s public health system with
respect to the detection of, and prompt response to, dis-
ease outbreaks [31]. Following the epidemic, the country’s
infectious disease surveillance infrastructure underwent a
massive overhaul, which included construction of new in-
fectious disease facilities and laboratories that were crucial
to improving the quality of surveillance data, as well as
facilitation of improved data sharing and of more effi-
cient coordination between public health agencies. The
overhaul also included a complete redesign of the real-
time infectious disease reporting system [51], as well as
the Ministry of Health's listing of schistosomiasis among
diseases such as HIV/AIDS, tuberculosis and hepatitis B
as a high priority for control [25]. This classification raised
the profile of the disease among public health officials,
increased the commitment of health care workers and
government agencies to schistosomiasis elimination,
and stimulated heightened surveillance and control ef-
forts [43,52].
Throughout these major transitions, China has made
remarkable progress towards controlling schistosomiasis.
The country’s evolving, parallel surveillance systems have
each played a distinct role in characterizing the dynamic
state of schistosomiasis transmission across diverse regions
of the country. Thus far, the systems and the informationthey provide have been used independently; numerous
reports, based on routine surveys, sentinel surveys and
national surveys have been published and used to de-
velop control strategies and monitor progress towards
achieving elimination. More recently, there has been an
effort to expand the use of these data beyond endemic
disease control. Routine surveillance data, for instance, has
been used to provide evidence of re-emerging schistosom-
iasis in Sichuan Province in areas that had previously
achieved local control [7]. Surveillance data from mul-
tiple systems can be fruitfully combined, as evidenced
by integration of national and NIDRS surveillance data
from all provinces to estimate the incidence, prevalence
and disease burden of schistosomiasis, as well as malaria,
hookworm and other water, sanitation, and hygiene-
associated infections [53]. The analysis revealed large
regional disparities in the burden of these infections,
particularly among children, who experience the greatest
risk of water, sanitation and hygiene-attributable disease in
China. In a separate study, combined national and NIDRS
data were used to estimate the future burden of these in-
fections under climate change [54]. While this work dem-
onstrates the value of China’s parallel surveillance systems,
understanding of how data from these systems can be ef-
fectively combined, to characterize and inform the many
dimensions of disease transmission and control, remains
limited.
The overlapping nature of these systems, both spatially
and temporally, provides a unique opportunity to explore
how a country can maximize the value of multiple, dis-
tinctive information sources to inform public health
campaigns and investments. This in an area where future
research is needed both in China and elsewhere. Further-
more, as many provinces move towards schistosomiasis
elimination and case detection becomes ever more chal-
lenging and expensive, it will be even more important
to determine how the data, sampling approaches, and
detection methods these systems provide can be used to
optimize the performance of surveillance efforts. Success-
ful schistosomiasis elimination will require the ability to
efficiently and accurately identify the few remaining in-
fected individuals and non-human reservoirs among large
uninfected populations. This will be complicated by de-
creased diagnostic sensitivity owing to reduced infection
intensity, testing fatigue among residents as a result of
long-standing repeated examinations, and ever-increasing
health care costs associated with diagnosis. To be success-
ful, China’s surveillance system must be prepared to modify
sampling methods, reporting approaches and diagnostics
in response to new scientific and technological advances
and changing schistosomiasis infection patterns. Recent
attempts to establish diagnostic standards through the
systematic evaluation of an array of immunological as-
says [55] and new mobile reporting methods, discussed
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China's national disease burden continues its shift from
infectious diseases to chronic, non-communicable diseases
(NCDs), additional strain will be placed on surveillance
personnel and institutions currently devoted to infectious
disease, and opportunities for integrating the surveillance
and care of NCDs and infectious diseases will be needed
[56,57]. Care must be taken to ensure that the resources
are adequate and to avoid surveillance fatigue among
healthcare workers and those in sentinel villages.
For China, research and innovations needed to succeed
in continuing control and elimination of schistosomiasis
include the development of diagnostic tools with higher
sensitivity for the detection of human infections, and new
ways of assessing human susceptibility to infection. In
addition, effective ways to deploy recently developed tools
for detecting the infectious stage of schistosomes (cercariae)
in the natural environment [30,58,59] will be needed. Like-
wise, mobile disease reporting technologies (e.g. use of
mobile phones or positioning systems with wireless cap-
ability for spatially explicit reporting of cases or vectors)
show considerable promise and have been recently applied
for surveillance of other neglected tropical diseases [60].
These technologies have been used in field surveys of
schistosomiasis endemic areas, to file reports of acute
cases and infected snails into a centralized surveillance
database [9], and to coordinate responses to disease out-
breaks after the 2008 earthquake in Sichuan province
[16,61]. Yet effective integration of mobile technologies
into large-scale surveillance procedures is still relatively
new, and will need further evaluation. At the same time,
new approaches will be needed to estimate the cost-
effectiveness of the combination of existing surveillance
systems in achieving specific surveillance endpoints, such
as a characterization of spatial and temporal variability
in cases. While considerable effort has been devoted to
evaluating surveillance systems from a functional stand-
point [62-66] —assessing timeliness [67], record accuracy
[68,69] and enhancing operational efficiency [70-72] —few
analytical tools exist for quantitatively assessing how
changes to design translate into improved (or inferior)
estimates of the underlying rates of disease taking into
account system sensitivity, coverage, bias and other fac-
tors. Development of such tools in China would provide a
useful precedent as schistosomiasis surveillance is increas-
ingly brought online in other countries.
Global lessons
Globally, there is a major movement underway to reduce
the burden of helminthiases. The priorities for the global
control and elimination of schistosomiasis, along with
STHs, were articulated by the WHO in 2013 [73]. The
surveillance needs of these global efforts are immense.
Nearly 240 million people, most of whom live in sub-Saharan Africa, are estimated to require preventive chemo-
therapy for schistosomiasis alone as of 2009, yet coverage
is reaching only 8% of those in need [74,75]. While many
factors contribute to this deficit, the lack of surveillance
capabilities in nearly all schistosomiasis-endemic countries
is a major obstacle to efficiently expanding coverage [74].
Accurate, timely, country-level data are generally unavail-
able, and targeting drug delivery for schistosomiasis control
in these settings is predominantly based on risk maps
generated using ad-hoc epidemiological data (e.g., research
data, historical drug delivery data, etc.), rather than sur-
veillance [76]. China’s history with surveillance of schisto-
somiasis can serve as a guide for countries, in sub-Saharan
Africa and elsewhere, that require low-cost, simple surveil-
lance and diagnostic technologies.
Given the current efforts to roll-out preventative chemo-
therapy, there will be a need to identify areas where disease
burden is declining and mass-treatment efforts can be
transitioned to targeted treatment and monitoring, as well
as areas where disease burden is not declining, where
more broad control efforts are needed. Throughout Africa,
where over 90% of schistosomiasis cases occur [77], the
capacity to conduct population-based surveys is limited
[78], and current control recommendations do not include
surveillance activities [74]. There is some movement
towards developing the infrastructure for parallel active
surveillance systems—sentinel systems to track progress of
control strategies coupled with regular provincial surveys—
in highly endemic areas. China’s sentinel systems offer
a model for deploying targeted surveillance resources
and monitoring control progress over time. Similar to
China’s provincial surveys, which borrow from standard-
ized national survey protocols, province-level schistosom-
iasis mapping of all endemic districts has recently begun
in a few countries (e.g. Ethiopia), and is rapidly scaling up
for other neglected tropical diseases such as trachoma,
with the benefit of funds provided by the UK Department
for International Development and The Bill & Melinda
Gates Foundation [79]. These efforts are moving incre-
mentally towards the electronic collection and reporting of
epidemiological data, and may benefit from lessons learned
during China’s 2011 adoption of a simple, internet-based
system to file, store and manage routine survey data. Cru-
cially, this system provides a model for electronic data
collection even in the absence of a sophisticated NIDRS
capacity. As many low-resource countries aspire for con-
trol and even elimination of schistosomiasis, understand-
ing the synergy of parallel systems will prove cost-effective
both by reducing unnecessary redundancy in data collec-
tion and in maximizing programming dollars. The systems
described in China have distinct utility, but how these sys-
tems may be translated to other areas of schistosomiasis
endemicity is not yet known and must be explored. Look-
ing forward, targeted surveillance capacity is needed to
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of rapid environmental, social, and technological changes,
such as the construction of dams and changes in agricul-
tural practices, that can result in an upsurge in schisto-
somiasis cases [54,77,80-82]. China’s sentinel system offers
a model for deploying targeted surveillance capacity in
regions undergoing such changes [83].
Optimal surveillance of schistosomiasis and other
neglected tropical diseases must evolve with changing
programmatic needs and technical advances. Currently,
real-time electronic surveillance is limited by lack of broad-
band internet infrastructure in many rural schistosomiasis-
endemic areas. However, mobile disease reporting
technologies offer new opportunities in areas where trad-
itional means of communication are limited [6], and may
become increasingly relevant as attention turns to elimin-
ation. In the context of elimination, new diagnostic tools
are urgently needed that offer rapid, sensitive, low-cost al-
ternatives to current methods. China is currently dealing
with this issue [14], and as other settings move towards
achieving elimination, the traditional diagnostics that are
currently relied upon by many surveillance systems will
need to be replaced [84]. Recently developed methods
offer improved opportunities for point-of-care surveillance
(e.g., [85]), and future investments will be needed to
ensure advances like these are pursued and, ultimately,
incorporated into surveillance practice.
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